Simian Acquired Immunodeficiency Syndrome
"Simian Acquired Immunodeficiency Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; (MPMV), or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS.
| Descriptor ID |
D016097
|
| MeSH Number(s) |
C02.782.815.616.850 C02.839.850 C22.735.500.850
|
| Concept/Terms |
Simian Acquired Immunodeficiency Syndrome- Simian Acquired Immunodeficiency Syndrome
- Simian AIDS
- Simian Acquired Immuno-Deficiency Syndrome
- Simian Acquired Immuno Deficiency Syndrome
- Simian Acquired Immune Deficiency Syndrome
- AIDS, Simian
- AIDSs, Simian
- Simian AIDSs
- SAIDS
|
Below are MeSH descriptors whose meaning is more general than "Simian Acquired Immunodeficiency Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Simian Acquired Immunodeficiency Syndrome".
This graph shows the total number of publications written about "Simian Acquired Immunodeficiency Syndrome" by people in this website by year, and whether "Simian Acquired Immunodeficiency Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 3 | 1 | 4 |
| 2020 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Simian Acquired Immunodeficiency Syndrome" by people in Profiles.
-
Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model. J Clin Invest. 2022 02 01; 132(3).
-
Antiretroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV coinfection model. J Clin Invest. 2020 10 01; 130(10):5171-5179.
-
Chronic Immune Activation in TB/HIV Co-infection. Trends Microbiol. 2020 08; 28(8):619-632.
-
Mechanisms of reactivation of latent tuberculosis infection due to SIV coinfection. J Clin Invest. 2019 12 02; 129(12):5254-5260.
-
Mucosal-activated invariant T cells do not exhibit significant lung recruitment and proliferation profiles in macaques in response to infection with Mycobacterium tuberculosis CDC1551. Tuberculosis (Edinb). 2019 05; 116S:S11-S18.
-
HIV-1 and SIV Infection Are Associated with Early Loss of Lung Interstitial CD4+ T Cells and Dissemination of Pulmonary Tuberculosis. Cell Rep. 2019 02 05; 26(6):1409-1418.e5.
-
CD4 receptor diversity in chimpanzees protects against SIV infection. Proc Natl Acad Sci U S A. 2019 02 19; 116(8):3229-3238.
-
Nonpathologic Infection of Macaques by an Attenuated Mycobacterial Vaccine Is Not Reactivated in the Setting of HIV Co-Infection. Am J Pathol. 2017 Dec; 187(12):2811-2820.
-
Socioecological correlates of clinical signs in two communities of wild chimpanzees (Pan troglodytes) at Gombe National Park, Tanzania. Am J Primatol. 2018 01; 80(1).
-
Destabilization of the gut microbiome marks the end-stage of simian immunodeficiency virus infection in wild chimpanzees. Am J Primatol. 2018 01; 80(1).